Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection

Clinical Biochemistry

Volumn 31, Issue 5, 1998, Pages 329-333

  Nicholls, Andrew J ^a  

^a Roche Global Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO;

AREA UNDER THE CURVE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG MONITORING; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; PHARMACODYNAMICS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

DRUG MONITORING; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; METABOLIC CLEARANCE RATE; MYCOPHENOLIC ACID;

EID: 0032128401     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00056-3     Document Type: Conference Paper

References (10)

1. Sollinger H.W. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation. 60:1995;225-232.
2. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation. 61:1996;1029-1037.
3. Anonymous. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet. 345:1995;1321-1325.
4. Hoffman-La Roche Inc. Mycophenolate mofetil prescribing information. Nutley, NJ: 1995.
5. Takahashi K., Ochiai T., Uchida K., et al. Pilot study of mycophenolate mofetil (RS- 61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee - Japan. Transplant Proc. 27:1995;1421-1424.
6. Tsina I., Chu F., Hama K., et al. Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma. J Chromatogr B Biomed Sci Appl. 675:(1):1996;119-129.
7. Verweij P.J., van Houwelingen H.C. Time-dependent effects of fixed covariates in Cox regression. Biometrics. 51:1995;1550-1556.
8. Hosmer D.W., Lemeshow S. Applied logistic regression. 1989;John Wiley & Sons Inc, NY.
9. Bullingham R.E., Nicholls A., Hale M. Pharmacokinetics of mycophenolate mofetil (RS61443) a short review . Transplant Proc. 28:1996;925-929.
10. Sanathanan L.P., Peck C.C. The randomized concentration-controlled trial an evaluation of its sample size efficiency . Control Clin Trials. 12:1991;780-794.